Evidence map›Paper›PMID 30475262›Full record

ReviewAIDS (London, England)2019

Eliminating perinatal HIV in the United States: mission possible?

Devasena Gnanashanmugam, Natella Rakhmanina, Keith W Crawford, Steven Nesheim, Theodore Ruel, Guthrie S Birkhead, Rana Chakraborty, Robert Lawrence, Patrick Jean-Philippe, Lakshmi Jayashankar and 8 more

Abstract readEditorialReview
In one paragraph

Review in AIDS (London, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Efficacy and Safety of Bictegravir-Based Regimen in Pregnant Women Living with HIV: A Case Report.Journal of the International Association of Providers of AIDS Care
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Devasena GnanashanmugamDivision of AIDS, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland.
Natella RakhmaninaChildren's National Medical Center, Elizabeth Glaser Pediatric AIDS Foundation, Washington, District of Columbia.
Keith W CrawfordDivision of AIDS, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland.
Steven NesheimCenters for Disease Control and Prevention (Division of HIV/AIDS Prevention), Atlanta, Georgia.
Theodore RuelUniversity of California- San Francisco, San Francisco, California.
Guthrie S BirkheadSchool of Public Health, University at Albany, Albany, New York.
Rana ChakrabortyEmory University School of Medicine, Atlanta, Georgia.
Robert LawrenceUniversity of Florida, Gainesville, Florida.
Patrick Jean-PhilippeDivision of AIDS, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland.
Lakshmi JayashankarColumbus Technologies Inc., Contractor to National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland.
Ashley HooverLouisiana State Department of Health, Baton Rouge, Louisiana.
Anne StattonPediatric AIDS Chicago Prevention Initiative, Chicago, Illinois.
Patricia DʼSouzaDivision of AIDS, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland.
Joseph FitzgibbonDivision of AIDS, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland.
Rohan HazraEunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland.
Barbara WarrenNew York State Department of Health, Albany, New York.
Somer SmithEmory University School of Medicine, Atlanta, Georgia.
Elaine J AbramsICAP at Columbia University, Mailman School of Public Health and Vagelos College of Physicians & Surgeons, Columbia University, New York, New York, USA.

Funding

LOC-IMPAACT Leadership GroupPharmacokinetics and Safety of Remdesivir for Treatment of COVID-19 in Pregnant Women in the USUM1AI068632 · NIAID · SOCIAL AND SCIENTIFIC SYSTEMS, INC. · PI Jennifer Jao, Sharon A Nachman · 2011 to 2026
$278.1M
Intramural NIH HHS Z99 AI999999
6 · The paper itself

Abstract

: In 2015, only 53 infants born in the United States acquired HIV - the lowest recorded number of perinatal HIV infections. Recognizing this significant achievement, we must acknowledge that the United States has not yet reached the goal of eliminating perinatal HIV transmission. This analysis describes different approaches to perinatal HIV preventive services among five states and the District of Columbia as case studies. Continuous focus on improving identification, surveillance and prevention of HIV infection in pregnant women and their infants is necessary to reach the goal of eliminating perinatal HIV transmission in the United States.

Indexed as

Communicable Disease ControlHIV InfectionsHumansInfectious Disease Transmission, VerticalUnited States

Identifiers

PMID30475262
PMCPMC6355361

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.